The mechanism is tied to glucagon receptor activation, which has a direct stimulatory effect on the sinoatrial node in the heart
A: If you have Type 2 diabetes, you may be able to after you discuss this with your doctor
However, it is noteworthy that a similar proportion of patients in both groups achieved a clinically significant total body weight loss of 5% or more and 10% or more at 12 months, which indicates the efficacy of this medication for both groups of patients. Researchers performed a retrospective cohort study with data from 305 adults with overweight or obesity who received once-weekly subcutaneous semaglutide (Wegovy, Novo Nordisk) at a Mayo Clinic center from 2021 to Jan
Your provider can monitor blood glucose and adjust doses as needed
Schedule your complementary consultation by selecting SCHEDULE YOUR CONSULTATION or fill out the form below.
Additional information In this paper, an animal model of hepatic encephalopathy was used to examine vasogenic brain edema following acute liver failure